Details for New Drug Application (NDA): 209107
✉ Email this page to a colleague
NDA 209107 describes CETIRIZINE HYDROCHLORIDE HIVES RELIEF, which is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, Sun Pharm Inds Inc, Amneal Pharms Ny, Taro, and Torrent Pharms Llc, and is included in seven NDAs. It is available from twenty-seven suppliers. Additional details are available on the CETIRIZINE HYDROCHLORIDE HIVES RELIEF profile page.
The generic ingredient in CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
The generic ingredient in CETIRIZINE HYDROCHLORIDE HIVES RELIEF is cetirizine hydrochloride. There are thirty-nine drug master file entries for this compound. One hundred and fifty-eight suppliers are listed for this compound. Additional details are available on the cetirizine hydrochloride profile page.
Summary for 209107
| Tradename: | CETIRIZINE HYDROCHLORIDE HIVES RELIEF |
| Applicant: | Aurobindo Pharma Ltd |
| Ingredient: | cetirizine hydrochloride |
| Patents: | 0 |
Pharmacology for NDA: 209107
| Mechanism of Action | Histamine H1 Receptor Antagonists |
Medical Subject Heading (MeSH) Categories for 209107
Suppliers and Packaging for NDA: 209107
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 209107 | ANDA | WALGREEN CO. | 0363-0068 | 0363-0068-12 | 1 BOTTLE in 1 CARTON (0363-0068-12) / 40 CAPSULE in 1 BOTTLE |
| CETIRIZINE HYDROCHLORIDE ALLERGY | cetirizine hydrochloride | CAPSULE;ORAL | 209107 | ANDA | WALGREEN CO. | 0363-0068 | 0363-0068-53 | 1 BOTTLE in 1 CARTON (0363-0068-53) / 25 CAPSULE in 1 BOTTLE |
Profile for product number 001
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jul 20, 2018 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | OTC | Dosage: | CAPSULE;ORAL | Strength | 10MG | ||||
| Approval Date: | Jul 20, 2018 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
